(Reuters) - CVS Health (NYSE:CVS) beat quarterly profit estimates on Wednesday, as a decline in hospitalizations from COVID-19 helped bring down medical costs at its Aetna insurance business.
The company posted an adjusted profit of $1.99 per share, above estimates of $1.92 per share, according to Refinitiv IBES data.
CVS reaffirmed its full-year adjusted profit forecast of between $8.70 and $8.90 per share.